World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 25 May 2015
Main ID:  NCT02228252
Date of registration: 27/08/2014
Prospective Registration: No
Primary sponsor: Aarhus University Hospital
Public title: The Effect of Protein Quality and Time-factor by Consumption of a Pre-meal on Postprandial Lipemia in Subjects With the Metabolic Syndrome.
Scientific title: Whey Protein, Postprandial Lipemia and Cardiovascular Disease: Evaluation of the Effect of a Pre-meal of Whey Protein on Postprandial Lipiemia in Subjects With the Metabolic Syndrome and Type 2 Diabetes
Date of first enrolment: August 2014
Target sample size: 16
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02228252
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention  
Phase:  N/A
Countries of recruitment
Denmark
Contacts
Name:     Kjeld Hermansen, Prefessor
Address: 
Telephone:
Email:
Affiliation:  Aarhus University Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Central obesity (female > 80 cm; male > 94 cm) with two of the following parameters:

- Fasting triglycerides > 1.7 mmol/L

- Fasting HDL-cholesterol < 1.03 mmol/L (female) or <1.29 mmol/L (male)

- Blood pressure = 130/85 mmHg

- Fasting plasma glucose = 5.6 mmol/L Subjects who are in medical treatment with lipid
and/or blood pressure-lowering habitual treatment can participate provided that the
treatment is stable throughout the trial.

Exclusion Criteria:

- Type 1 diabetes

- Type 2 diabetes (HbA1c = 48 mmol/L)

- Fasting plasma triglycerides > 5.0 mmol/L

- Blood pressure > 160/100 mmHg

- Cardiovascular, liver, kidney or metabolic disease

- Corticosteroid treatment

- Pregnancy or lactation

- Alcohol or drug abuse

- Legal incapacity



Age minimum: 18 Years
Age maximum: 75 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Metabolic Syndrome
Intervention(s)
Other: Gluten protein
Other: Whey protein
Other: Casein
Primary Outcome(s)
Effect on apolipoprotein B48 of whey protein as pre-meal after a high-fat meal in subjects with the metabolic syndrome measured as incremental Area Under the Curve (iAUC -15 - 360 min). [Time Frame: Prior to the pre meal (-30/-15 min), prior to the main meal (0 min) and 120, 240 and 360 min post main meal.]
Effect on triglyceride response of whey protein as pre-meal after a high-fat meal in subjects with the metabolic syndrome measured as incremental Area Under the Curve (iAUC -15 - 360 min). [Time Frame: Prior to the pre meal (-30/-15 min), prior to the main meal (0 min) and 60, 90, 120, 180, 240 and 360 min post main meal.]
Secondary Outcome(s)
Glucose responses measured as incremental Area Under the Curve (AUC -30/-15 - 360 min) [Time Frame: Prior to the pre meal (-30, -25) -15 min, (-10 min), prior to the main meal (0 min) and 15, 30, 60, 90, 120, 240 and 360 min post main meal.]
Gastric inhibitory peptide (GIP) responses measured as incremental Area Under the Curve (AUC -30/-15 - 360 min) [Time Frame: Prior to the pre meal (-30, -25) -15 min, (-10 min), prior to the main meal (0 min) and 15, 30, 60, 90, 120, 240 and 360 min post main meal.]
Glucagon responses measured as incremental Area Under the Curve (AUC -30/-15 - 360 min) [Time Frame: Prior to the pre meal (-30, -25) -15 min, (-10 min), prior to the main meal (0 min) and 15, 30, 60, 90, 120, 240 and 360 min post main meal.]
Insulin responses measured as incremental Area Under the Curve (AUC -30/-15 - 360 min) [Time Frame: Prior to the pre meal (-30, -25) -15 min, (-10 min), prior to the main meal (0 min) and 15, 30, 60, 90, 120, 240 and 360 min post main meal.]
Glucagon-like peptide 1 (GLP-1) responses measured as incremental Area Under the Curve (AUC -30/-15 - 360 min) [Time Frame: Prior to the pre meal (-30, -25) -15 min, (-10 min), prior to the main meal (0 min) and 15, 30, 60, 90, 120, 240 and 360 min post main meal.]
Secondary ID(s)
CERN-Premeal2
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Aarhus
University of Copenhagen
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history